Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Y Feng

Showing results (1-10 of 459) with videos related to

Pageof 46
Sort By:
Asian Journal of Andrology|April 14, 2016
Long noncoding RNAs in prostate cancer: overview and clinical implicationsBhavna Malik, Felix Y Feng
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2016
Driven to metastasize: Kinases as potential therapeutic targets in prostate cancerFelix Y Feng, Vishal Kothari
Cell|March 23, 2019
A Tumor-Agnostic NTRK (TRK) InhibitorFranklin W Huang, Felix Y Feng
Urology|November 30, 2014
Editorial commentTodd M Morgan, Felix Y Feng
Nature|April 20, 2019
Lethal clues to cancer-cell vulnerabilityFelix Y Feng, Luke A Gilbert
Nature Clinical Practice. Oncology|July 3, 2008
Radiation therapy improves survival in patients with pancreatic adenocarcinomaFelix Y Feng, Edgar Ben-Josef
European Urology|March 20, 2019
Expanding Role of Germline DNA Repair Alterations in Prostate Cancer Risk and Early OnsetKaren E Knudsen, Felix Y Feng
European Urology|February 26, 2019
"Lincing" the Y Chromosome to Prostate Cancer: TTTY15 Takes Center StageJohn R Prensner, Felix Y Feng
European Urology Oncology|May 18, 2019
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?Daniel E Spratt, Felix Y Feng
European Urology Focus|February 13, 2019
Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate CancerCécile Vicier, Felix Y Feng, Karim Fizazi
Pageof 46

Showing results (1-10 of 459) with videos related to

Sort By:
Pageof 46
Asian Journal of Andrology|April 14, 2016
Long noncoding RNAs in prostate cancer: overview and clinical implicationsBhavna Malik, Felix Y Feng
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2016
Driven to metastasize: Kinases as potential therapeutic targets in prostate cancerFelix Y Feng, Vishal Kothari
Cell|March 23, 2019
A Tumor-Agnostic NTRK (TRK) InhibitorFranklin W Huang, Felix Y Feng
Urology|November 30, 2014
Editorial commentTodd M Morgan, Felix Y Feng
Nature|April 20, 2019
Lethal clues to cancer-cell vulnerabilityFelix Y Feng, Luke A Gilbert
Nature Clinical Practice. Oncology|July 3, 2008
Radiation therapy improves survival in patients with pancreatic adenocarcinomaFelix Y Feng, Edgar Ben-Josef
European Urology|March 20, 2019
Expanding Role of Germline DNA Repair Alterations in Prostate Cancer Risk and Early OnsetKaren E Knudsen, Felix Y Feng
European Urology|February 26, 2019
"Lincing" the Y Chromosome to Prostate Cancer: TTTY15 Takes Center StageJohn R Prensner, Felix Y Feng
European Urology Oncology|May 18, 2019
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?Daniel E Spratt, Felix Y Feng
European Urology Focus|February 13, 2019
Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate CancerCécile Vicier, Felix Y Feng, Karim Fizazi
Pageof 46